Cargando...
Novel peptide isomer strategy for stable inhibition of catecholamine release: Application to hypertension
Although hypertension remains the most potent and widespread cardiovascular risk factor, its pharmacological treatment has achieved only limited success. The chromogranin A derived fragment catestatin inhibits catecholamine release by acting as an endogenous nicotinic cholinergic antagonist, and can...
Guardado en:
| Autores principales: | , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2012
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3523723/ https://ncbi.nlm.nih.gov/pubmed/23129699 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/HYPERTENSIONAHA.112.202127 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|